Effect of L-arginine on expression of GFAP in kainic acid-induced seizure

YiPing Sun,GuoZhu Han,Changkai Sun,Hua Chen,Dezheng Gong,ShengMing Yin,Xu Jing,DeQin Yu,DongMei Wang,Hong Xu

2011-01-01

Abstract:Aim: To explore the effects of L-arginine (L-Arg), the nitric oxide synthase (NOS) substrate, on seizure with rats. Methods: Rats were randomly divided into 6 groups: NS group were intraperitoneally injected with normal saline (NS) 2 ml/kg twice a day for 5 days, NS+KA group were administrated KA (10mg/kg) after pretreatment with NS, L-Arg group were intraperitoneally injected with L-Arg (40mg/kg) twice a day for 5 days, L-Arg+KA group I, II and III were administrated KA (10mg/kg) after pretreatment with L-Arg 10 mg/kg, 40mg/kg and 160 mg/kg respectively. Seizure behavior, expression of glial fibrillary acidic protein in astrocytes by the way of immunoreactivity (GFAP-ir) and western blotting were observed during 3 hours administration of KA. Results: L-Arg pretreatment in dose of 40mg/kg significantly alleviated seizures induced by KA, whereas the latency of wet dog shake and convulsions were prolonged as well as the seizure score was lowered (p<0.01). L-Arg pretreatment also inhibited the hyperplasia and hypertrophy of the astrocytes. Simultaneously bandlike distribution of astrocytes in seizure-related hippocampus decreased, because the expression of GFAP assayed by immunohistostaining and western blotting were lowered after 3 hours of injection of KA. Conclusion: Chronic injection of small dose of L-Arg (40mg/kg) may reduce seizure behaviors challenged by KA and prohibit the formation and location of astrocytes in hippocampus by inhibiting the expression of GFAP and protect the brain of seizure rats.